Zacks Investment Research Downgrades Vitamin Shoppe (NYSE:VSI) to Hold

Share on StockTwits

Zacks Investment Research cut shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a hold rating in a report issued on Thursday, Zacks.com reports.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

VSI has been the topic of several other research reports. Jefferies Financial Group initiated coverage on shares of Vitamin Shoppe in a research report on Monday, June 17th. They issued a hold rating and a $4.00 price target on the stock. ValuEngine upgraded shares of Vitamin Shoppe from a sell rating to a hold rating in a research report on Thursday, August 8th. Five research analysts have rated the stock with a hold rating, The stock currently has an average rating of Hold and a consensus target price of $8.42.

Vitamin Shoppe stock opened at $6.43 on Thursday. The company has a debt-to-equity ratio of 2.37, a quick ratio of 0.23 and a current ratio of 1.18. The firm has a market cap of $155.21 million, a price-to-earnings ratio of 24.73 and a beta of 1.68. Vitamin Shoppe has a 1 year low of $3.32 and a 1 year high of $13.95. The firm’s 50 day moving average price is $4.55 and its two-hundred day moving average price is $5.35.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Thursday, August 8th. The specialty retailer reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.08. The firm had revenue of $270.88 million for the quarter, compared to analyst estimates of $278.60 million. Vitamin Shoppe had a negative net margin of 0.66% and a positive return on equity of 3.34%. As a group, equities analysts predict that Vitamin Shoppe will post 0.55 EPS for the current fiscal year.

A number of institutional investors have recently bought and sold shares of VSI. VIEX Capital Advisors LLC grew its position in Vitamin Shoppe by 1,496.9% in the second quarter. VIEX Capital Advisors LLC now owns 2,198,449 shares of the specialty retailer’s stock worth $8,662,000 after buying an additional 2,060,782 shares during the last quarter. Invesco Ltd. grew its position in Vitamin Shoppe by 78.7% in the second quarter. Invesco Ltd. now owns 1,040,722 shares of the specialty retailer’s stock worth $4,100,000 after buying an additional 458,230 shares during the last quarter. California Public Employees Retirement System grew its position in Vitamin Shoppe by 151.2% during the 1st quarter. California Public Employees Retirement System now owns 343,005 shares of the specialty retailer’s stock worth $2,415,000 after purchasing an additional 206,438 shares in the last quarter. Acadian Asset Management LLC grew its position in Vitamin Shoppe by 81.4% during the 1st quarter. Acadian Asset Management LLC now owns 418,386 shares of the specialty retailer’s stock worth $2,944,000 after purchasing an additional 187,737 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Vitamin Shoppe by 92.5% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 330,179 shares of the specialty retailer’s stock worth $1,301,000 after purchasing an additional 158,620 shares in the last quarter. Hedge funds and other institutional investors own 89.41% of the company’s stock.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Recommended Story: Total Return

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

VANGUARD SCOTTS/VANGUARD RUSSELL 20  Shares Acquired by Wells Fargo & Company MN
VANGUARD SCOTTS/VANGUARD RUSSELL 20 Shares Acquired by Wells Fargo & Company MN
$1.41 EPS Expected for Burlington Stores Inc  This Quarter
$1.41 EPS Expected for Burlington Stores Inc This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc  This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc This Quarter
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc


© 2006-2019 Ticker Report